National Health (Minimum Stockholding) Amendment Determination (No. 8) 2026

Contents

1Name#

(1)This instrument is the National Health (Minimum Stockholding) Amendment Determination (No. 8) 2026.

(2)This instrument may also be cited as PB 106 of 2026.

2Commencement#

These Regulations shall come into force on 17th March 1987 and shall have effect as from 25th November 1982.

Commencement information
Column 1	Column 2	Column 3
Provisions	Commencement	Date/Details
1. Sections 1 to 4 and anything in this instrument not elsewhere covered by this table	1 September 2026.	1 September 2026
2. Schedule 1	1 September 2026.	1 September 2026

(2)Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

3Authority#

This instrument is made under subsection 99AEKC(2) of the National Health Act 1953.

4Schedules#

Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.

Schedule 1 · Amendments commencing 1 September 2026

National Health (Minimum Stockholding) Determination 2023 #

1 Schedule 1 (table)

Omit:

Amoxicillin

Capsule 250 mg (as trihydrate)

Oral

Amoxil

between 1 April 2026 to 31 August 2026—0 months stock by reference to usual demand

2 Schedule 1 (table)

Omit:

Aripiprazole

Tablet 20 mg

Oral

ARIPIPRAZOLE-WGR

between 1 July 2026 to 31 August 2026—0 months stock by reference to usual demand

3 Schedule 1 (table)

After:

Bivalirudin

Powder for I.V. injection 250 mg (as trifluoroacetate)

Injection

BIVALIRUDIN ARX

4 months stock by reference to usual demand of both Bivalirudin APOTEX and BIVALIRUDIN ARX added together

insert:

Bortezomib

Powder for injection 3 mg

Injection

DBL Bortezomib

between 1 September 2026 to 30 November 2026—0 months stock by reference to usual demand

4 Schedule 1 (table)

After:

Codeine

Tablet containing codeine phosphate hemihydrate 30 mg

Oral

Aspen Pharmacare Australia Pty Ltd

4 months stock by reference to usual PBS demand

insert:

Codeine with paracetamol

Tablet containing codeine phosphate hemihydrate 30 mg with paracetamol 500 mg

Oral

Paracetamol/Codeine GH 500/30

between 1 September 2026 to 31 January 2027—0 months stock by reference to usual demand

5 Schedule 1 (table)

After:

Dantrolene

Capsule containing dantrolene sodium hemiheptahydrate 25 mg

Oral

Dantrium

6 months stock by reference to usual PBS demand

insert:

Deferasirox

Tablet 180 mg

Oral

DEFERASIROX-TEVA

between 1 September 2026 to 31 January 2027—0 months stock by reference to usual demand

6 Schedule 1 (table)

Omit:

Diltiazem

Capsule (controlled delivery) containing diltiazem hydrochloride 360 mg

Oral

Cardizem CD

between 1 August 2026 and 31 August 2026—0 months stock by reference to usual demand

7 Schedule 1 (table)

Omit:

Glimepiride

Tablet 3 mg

Oral

GLIMEPIRIDE-WGR

between 1 March 2026 to 31 August 2026—0 months stock by reference to usual demand

8 Schedule 1 (table)

After:

Imatinib

Capsule 400 mg (as mesilate)

Oral

ARX-IMATINIB

3 months stock by reference to usual demand of both Imatinib-APOTEX and ARX-IMATINIB added together

insert:

Imatinib

Tablet 600 mg (as mesilate)

Oral

Imatab

between 1 September 2026 to 30 November 2026—0 months stock by reference to usual demand

9 Schedule 1 (table)

Omit:

Lamivudine

Tablet 300 mg

Oral

Lamivudine Alphapharm

between 1 July 2026 to 31 August 2026—0 months stock by reference to usual demand

insert:

Lamivudine

Tablet 300 mg

Oral

Lamivudine Viatris

4 months stock by reference to usual demand of both Lamivudine Alphapharm and Lamivudine Viatris added together

10 Schedule 1 (table)

After:

Macrogol 3350

Sachets containing powder for oral solution 13.125 g with electroylytes, 30

Oral

Chemists’ Own Constipation Relief with Electrolytes

4 months stock by reference to usual demand of both Chemists’ Own Macrogol with Electrolytes and Chemists’ Own Constipation Relief with Electrolytes added together

insert:

Meloxicam	Capsule 7.5 mg	Oral	Mobic	between 1 September 2026 to 31 January 2027—0 months stock by reference to usual demand
Meloxicam	Capsule 15 mg	Oral	Mobic	between 1 September 2026 to 31 October 2026—0 months stock by reference to usual demand

11 Schedule 1 (table)

Omit:

Nevirapine

Oral suspension 50 mg (as hemihydrate) per 5 mL, 240 mL

Oral

Viramune

4 months stock by reference to usual PBS demand

insert:

Nevirapine

Oral suspension 50 mg (as hemihydrate) per 5 mL, 240 mL

Oral

Viramune

between 1 September 2026 to 31 January 2027—0 months stock by reference to usual PBS demand

12 Schedule 1 (table)

Omit:

Olanzapine

Tablet 20 mg (orally disintegrating)

Oral

OLANZAPINE ODT-WGR

between 1 March 2026 to 31 August 2026—0 months stock by reference to usual demand

13 Schedule 1 (table)

Omit:

Oxaliplatin

Solution concentrate for I.V. infusion 200 mg in 40 mL

Injection

Oxaliplatin SUN

between 1 March 2026 to 31 August 2026—0 months stock by reference to usual demand

14 Schedule 1 (table)

Omit:

Pioglitazone

Tablet 30 mg (as hydrochloride)

Oral

Actos

between 1 May 2026 and 31 August 2026—0 months stock by reference to usual demand

15 Schedule 1 (table)

After:

Salbutamol

Pressurised inhalation 100 micrograms (as sulfate) per dose with dose counter, 200 doses (CFC-free formulation)

Inhalation by Mouth

Zempreon CFC-Free with dose counter

4 months stock by reference to usual demand

insert:

Sertraline

Tablet 100 mg (as hydrochloride)

Oral

Sertraline generichealth

between 1 September 2026 to 31 December 2026—0 months stock by reference to usual demand

16 Schedule 1 (table)

After:

Trandolapril

Capsule 500 micrograms

Oral

Dolapril 0.5

2.5 months stock by reference to usual demand

insert:

Trastuzumab

Powder for I.V. infusion 420 mg

Injection

Kanjinti

between 1 September 2026 to 30 November 2026—0 months stock by reference to usual demand

Sourced from the Federal Register of Legislation at legislation.gov.au, © Commonwealth of Australia, licensed under CC BY 4.0. Compilations may have been reformatted.

National Health (Minimum Stockholding) Amendment Determination (No. 8) 2026

1Name#

2Commencement#

3Authority#

4Schedules#

Schedule 1 · Amendments commencing 1 September 2026

National Health (Minimum Stockholding) Determination 2023 #

History · 1 version

Key facts

1Name#

2Commencement#

3Authority#

4Schedules#

Schedule 1 · Amendments commencing 1 September 2026

National Health (Minimum Stockholding) Determination 2023 #

1Name#

2Commencement#

3Authority#

4Schedules#

Schedule 1 · Amendments commencing 1 September 2026

National Health (Minimum Stockholding) Determination 2023#

History · 1 version

Key facts

1Name#

2Commencement#

3Authority#

4Schedules#

Schedule 1 · Amendments commencing 1 September 2026

National Health (Minimum Stockholding) Determination 2023#

National Health (Minimum Stockholding) Determination 2023 #

National Health (Minimum Stockholding) Determination 2023 #